Status:
COMPLETED
Behavioral Insomnia Therapy for Fibromyalgia
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions:
Fibromyalgia
Insomnia
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
This study tests the effectiveness of a nondrug treatment for the insomnia that often occurs in people with fibromyalgia. The treatment is a type of psychotherapy called cognitive-behavioral therapy. ...
Detailed Description
Fibromyalgia (FM) is a prevalent and debilitating condition that contributes to impaired occupational and social functioning and increased disability among affected individuals. The vast majority of p...
Eligibility Criteria
Inclusion Criteria:
- Insomnia for more than 1 month
- Fibromyalgia diagnosis
- Participants must live within easy commuting distance of Duke Medical Center, Durham, North Carolina
Exclusion Criteria:
- Terminal illness
- Major psychiatric disorder
- Substance abuse
- Dependence on hypnotic drugs
- Other sleep disorders (sleep apnea, restless legs, etc.)
- Other sleep-disturbing medical disorders (painful arthritis, thyroid condition, etc.)
Key Trial Info
Start Date :
July 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2004
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT00000397
Start Date
July 1 1999
End Date
September 1 2004
Last Update
July 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710